Healthcare & Life Sciences

Riva Therapeutics

activeseries-a
series-a
Stage
4
Investors

About

Riva Therapeutics is a precision oncology company focused on developing new small molecule therapeutics that selectively target essential tumor cell processes to create transformative and well-tolerated cancer medicines.

Explore Riva Therapeutics's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.